These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11501494)

  • 1. Soluble forms of P-, E- and L-selectin in children with Kawasaki disease.
    Furui J
    Kurume Med J; 2001; 48(2):135-43. PubMed ID: 11501494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble forms of the selectin family in children with Kawasaki disease: prediction for coronary artery lesions.
    Furui J; Ishii M; Ikeda H; Muta H; Egami K; Sugahara Y; Himeno W; Akagi T; Kato H; Matsuishi T
    Acta Paediatr; 2002; 91(11):1183-8. PubMed ID: 12463316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating soluble selectins in Kawasaki disease.
    Takeshita S; Dobashi H; Nakatani K; Koike Y; Tsujimoto H; Hirayama K; Kawamura Y; Mori K; Sekine I; Yoshioka S
    Clin Exp Immunol; 1997 Jun; 108(3):446-50. PubMed ID: 9182890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment.
    Schiller B; Elinder G
    Acta Paediatr; 1999 Aug; 88(8):844-8. PubMed ID: 10503683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
    Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
    Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
    Głowińska B; Urban M; Peczyńska J; Florys B
    Przegl Lek; 2004; 61(9):935-9. PubMed ID: 15803902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
    Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma levels of soluble selectins in patients with unstable angina.
    Atalar E; Aytemir K; Haznedaroğlu I; Ozer N; Ovünç K; Aksöyek S; Kes S; Kirazli S; Ozmen F
    Int J Cardiol; 2001 Mar; 78(1):69-73. PubMed ID: 11259814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease　- A Multicenter Retrospective Study.
    Okuma Y; Suda K; Nakaoka H; Katsube Y; Mitani Y; Yoshikane Y; Ichida F; Matsushita T; Shichino H; Shiraishi I; Abe J; Hiroe M; Yoshida T; Imanaka-Yoshida K
    Circ J; 2016 Oct; 80(11):2376-2381. PubMed ID: 27746411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
    Yi L; Zhang J; Zhong J; Zheng Y
    J Interferon Cytokine Res; 2020 Mar; 40(3):159-167. PubMed ID: 31841639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in 25-hydroxyvitamin D3 level and its significance in children with Kawasaki disease].
    Zhang YD; Li RM; Ji CY; Zhang XL; Zhang Y; Dong QW; Ma L
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Mar; 18(3):211-4. PubMed ID: 26975816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease.
    Qi Y; Gong F; Zhang Q; Xie C; Wang W; Fu S
    Arthritis Res Ther; 2012 Nov; 14(6):R251. PubMed ID: 23171632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating soluble L-selectin levels in Kawasaki disease with coronary artery lesions.
    Hirao J; Yamashita T
    Acta Paediatr Jpn; 1997 Apr; 39(2):290-2. PubMed ID: 9141275
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical analysis of 942 cases of Kawasaki disease].
    Zhang W; Li Q; Zhao XD; Tang XM; Wang XG; Wang M; Wu DQ; Ou Q; Yang XQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):324-8. PubMed ID: 16780705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions.
    Xia Y; Tian X; Li Q; Wang G; Li C; Yang J
    Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis.
    Zheng X; Li J; Yue P; Liu L; Li J; Zhou K; Hua Y; Li Y
    PLoS One; 2021; 16(3):e0248812. PubMed ID: 33764989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.